May 25, 2024
Precision medicine improves outcomes in metastatic breast cancer

Precision medicine improves outcomes in metastatic breast cancer

  • CLINICAL BRIEFINGS
  • 07 September 2022

For breast cancers that have spread, a randomized phase II clinical trial shows that using genomic analysis to target therapies can improve outcomes, but only in people with a genetic alteration that has previously been associated with antitumour activity in clinical trials.

Source link